lactulose
Showing 1 - 25 of 52
Hepatic Encephalopathy, Chronic Liver Disease Trial (Tap water, Lactulose)
Not yet recruiting
- Hepatic Encephalopathy
- Chronic Liver Disease
- Tap water
- Lactulose
- (no location specified)
Apr 3, 2023
Hepatic Encephalopathy Trial in Cairo (Nifuroxazide, Lactulose)
Not yet recruiting
- Hepatic Encephalopathy
- Nifuroxazide
- Lactulose
-
Cairo, EgyptNational Hepatology and Tropical Medicine Research Institute (NH
Feb 23, 2023
Lactulose vs Lactobacillus Acidophilus Effect in CKD Patients
Not yet recruiting
- CKD
- Lactulose
- (no location specified)
Jun 28, 2023
Lactulose, Polyethylene Glycol, Bowel Preparation Trial in Montevideo (Lactulose, Polyethylene Glycol 3350)
Recruiting
- Lactulose
- +4 more
- Lactulose
- Polyethylene Glycol 3350
-
Montevideo, UruguayHospital de Clinicas
Feb 10, 2023
Hepatic Encephalopathy, Acute-On-Chronic Liver Failure Trial in Chandigarh (Branched chain amino acid, Lactulose)
Completed
- Hepatic Encephalopathy
- Acute-On-Chronic Liver Failure
- Branched chain amino acid
- Lactulose
-
Chandigarh, IndiaPGIMER
Aug 14, 2022
Liver Cirrhosis, Renal Failure Trial in New York (Rifaximin, Lactulose)
Withdrawn
- Liver Cirrhosis
- Renal Failure
- Rifaximin
- Lactulose
-
New York, New YorkWeill Cornell Medical Center
Jan 24, 2022
Cirrhosis Trial in Ann Arbor (Lactulose)
Completed
- Cirrhosis
- Lactulose
-
Ann Arbor, MichiganUniversity of Michigan
Nov 2, 2022
Cirrhosis, Liver, Portal Hypertension Trial in Ann Arbor, Philadelphia, Dallas (Enhanced Usual Care, Lactulose, Investigator
Not yet recruiting
- Cirrhosis, Liver
- Portal Hypertension
- Enhanced Usual Care
- +3 more
-
Ann Arbor, Michigan
- +2 more
Mar 20, 2023
Hepatic Encephalopathy Trial in Karachi (Polyethylene Glycols, Lactulose)
Recruiting
- Hepatic Encephalopathy
- Polyethylene Glycols
- Lactulose
-
Karachi, Sindh, PakistanAga Khan University
Jul 6, 2021
Hepatic Encephalopathy, Acute-On-Chronic Liver Failure Trial in Chandigarh (Branch Chain Amino Acid, Lactulose)
Recruiting
- Hepatic Encephalopathy
- Acute-On-Chronic Liver Failure
- Branch Chain Amino Acid
- Lactulose
-
Chandigarh, IndiaDr. Madhumita Premkumar
Jan 17, 2023
Colon Disease Trial (Lactulose, Polyethylene Glycol (PEG))
Not yet recruiting
- Colon Disease
- Lactulose
- Polyethylene Glycol (PEG)
- (no location specified)
Mar 10, 2021
Functional Dyspepsia, Constipation-predominant Irritable Bowel Syndrome Trial in Shanghai (Linaclotide, Lactulose, Omeprazol)
Recruiting
- Functional Dyspepsia
- Constipation-predominant Irritable Bowel Syndrome
- Linaclotide
- +3 more
-
Shanghai, Shanghai, ChinaRenJiH
Nov 29, 2021
Hepatic Encephalopathy, Liver Cirrhosis, End Stage Liver DIsease Trial (E.coli Nissle 1917, Lactulose, Rifaximin)
Completed
- Hepatic Encephalopathy
- +2 more
- E.coli Nissle 1917
- +2 more
- (no location specified)
Mar 5, 2021
Overt Hepatic Encephalopathy Trial in United States (40 mg Rifaximin SSD once daily, 40 mg Rifaximin SSD twice daily, 80 mg
Completed
- Overt Hepatic Encephalopathy
- 40 mg Rifaximin SSD once daily
- +5 more
-
Corona Del Mar, California
- +33 more
Mar 10, 2021
Constipation - Functional Trial in Jakarta (PEG 3350, Lactulose)
Active, not recruiting
- Constipation - Functional
- PEG 3350
- Lactulose
-
Jakarta, DKI Jakarta, Indonesia
- +2 more
Oct 19, 2020
Motility Disorder of Intestine, Ondansetron, Small Bowel Water Trial in Nottingham (Ondansetron 8mg, abdominal MRI, Lactulose)
Completed
- Motility Disorder of Intestine
- +2 more
- Ondansetron 8mg
- +3 more
-
Nottingham, Nottinghamshire, United KingdomUniversity of Nottingham
Nov 26, 2019
Refractory Hepatic Encephalopathy Trial in New Delhi (Lactulose, Rifaximin, Plasmapheresis)
Withdrawn
- Refractory Hepatic Encephalopathy
- Lactulose
- +2 more
-
New Delhi, Delhi, IndiaInstitute of Liver and Biliary Sciences
Nov 1, 2019
Hepatic Encephalopathy, Acute-On-Chronic Liver Failure Trial in Chandigarh (PEG-3350 with Electolytes, Lactulose)
Unknown status
- Hepatic Encephalopathy
- Acute-On-Chronic Liver Failure
- PEG-3350 with Electolytes
- Lactulose
-
Chandigarh, IndiaPostgraduate Institute of Medical Education and Research
Jun 14, 2019
Hepatic Encephalopathy Trial in Miami (Rifaximin, Lactulose, Placebo)
Terminated
- Hepatic Encephalopathy
- Rifaximin
- +2 more
-
Miami, FloridaCenter For Liver Diseases - University of Miami
Aug 27, 2019
Hepatic Encephalopathy, Cirrhosis Trial in United States (Rifaximin, Lactulose)
Completed
- Hepatic Encephalopathy
- Cirrhosis
- Rifaximin
- Lactulose
-
Phoenix, Arizona
- +42 more
Sep 6, 2019
Impaired Small Intestinal Permeability Trial in Rochester (12C mannitol, Indomethacin, 13C mannitol)
Completed
- Impaired Small Intestinal Permeability
- 12C mannitol
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jun 3, 2019
Liver Cirrhosis Trial in New Delhi (Nutrition, Lactulose, Diet)
Withdrawn
- Liver Cirrhosis
- Nutrition
- +2 more
-
New Delhi, Delhi, IndiaInstitute of Liver and Biliary Sciences
Dec 8, 2018
Hepatic Encephalopathy Trial in Mexico City (Lactulose, L-ornithine L-aspartate, Rifaximin)
Completed
- Hepatic Encephalopathy
- Lactulose
- +3 more
-
Mexico City, MexicoHospital General de Mexico
May 19, 2018
Acute-On-Chronic Liver Failure Trial in New Delhi (Lactulose + Rifaximin, Lactulose)
Completed
- Acute-On-Chronic Liver Failure
- Lactulose + Rifaximin
- Lactulose
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Feb 7, 2018